| Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions GM Lucas, RE Chaisson, RD Moore Annals of internal medicine 131 (2), 81-87, 1999 | 1081 | 1999 |
| Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic GM Lucas, KA Gebo, RE Chaisson, RD Moore Aids 16 (5), 767-774, 2002 | 418 | 2002 |
| Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection GM Lucas, LW Cheever, RE Chaisson, RD Moore JAIDS Journal of Acquired Immune Deficiency Syndromes 27 (3), 251-259, 2001 | 417 | 2001 |
| Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases … GM Lucas, MJ Ross, PG Stock, MG Shlipak, CM Wyatt, SK Gupta, MG Atta, ... Clinical Infectious Diseases 59 (9), e96-e138, 2014 | 382 | 2014 |
| Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study GM Lucas, JA Eustace, S Sozio, EK Mentari, KA Appiah, RD Moore Aids 18 (3), 541-546, 2004 | 338 | 2004 |
| HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study FL Altice, RD Bruce, GM Lucas, PJ Lum, PT Korthuis, TP Flanigan, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S22-S32, 2011 | 289 | 2011 |
| Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races GM Lucas, B Lau, MG Atta, DM Fine, J Keruly, RD Moore The Journal of infectious diseases 197 (11), 1548-1557, 2008 | 278 | 2008 |
| Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes GM Lucas, N Lechtzin, DW Puryear, LL Yau, CW Flexner, RD Moore Clinical infectious diseases 26 (5), 1127-1133, 1998 | 234 | 1998 |
| Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial LR Metsch, DJ Feaster, L Gooden, T Matheson, M Stitzer, M Das, MK Jain, ... JAMA 316 (2), 156-170, 2016 | 203 | 2016 |
| Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy GM Lucas, M Griswold, KA Gebo, J Keruly, RE Chaisson, RD Moore American Journal of Epidemiology 163 (5), 412-420, 2006 | 200 | 2006 |
| Buprenorphine use: the international experience MP Carrieri, L Amass, GM Lucas, D Vlahov, A Wodak, GE Woody Clinical Infectious Diseases 43 (Supplement 4), S197-S215, 2006 | 188 | 2006 |
| End-stage renal disease among HIV-infected adults in North America AG Abraham, KN Althoff, Y Jing, MM Estrella, MM Kitahata, CW Wester, ... Clinical Infectious Diseases 60 (6), 941-949, 2015 | 181 | 2015 |
| Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST) B Spire, GM Lucas, MP Carrieri International Journal of Drug Policy 18 (4), 262-270, 2007 | 172 | 2007 |
| Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven GM Lucas Journal of Antimicrobial Chemotherapy 55 (4), 413-416, 2005 | 165 | 2005 |
| Observations on a cohort of HIV-infected patients undergoing native renal biopsy AR Berliner, DM Fine, GM Lucas, MH Rahman, LC Racusen, PJ Scheel, ... American journal of nephrology 28 (3), 478-486, 2008 | 164 | 2008 |
| End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004 GM Lucas, SH Mehta, MG Atta, GD Kirk, N Galai, D Vlahov, RD Moore Aids 21 (18), 2435-2443, 2007 | 161 | 2007 |
| Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups GM Lucas, BA Mullen, PJ Weidle, S Hader, ME McCaul, RD Moore Clinical infectious diseases 42 (11), 1628-1635, 2006 | 161 | 2006 |
| Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic SH Mehta, GM Lucas, LB Mirel, M Torbenson, Y Higgins, RD Moore, ... Aids 20 (18), 2361-2369, 2006 | 157 | 2006 |
| Cerebral asymmetry and handedness. LE White, G Lucas, A Richards, D Purves Nature; Nature, 1994 | 150 | 1994 |
| An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002 RD Moore, JC Keruly, KA Gebo, GM Lucas JAIDS Journal of Acquired Immune Deficiency Syndromes 39 (2), 195-198, 2005 | 142 | 2005 |
